Testing the Effects of Resveratrol, Apigenin, and Glucosamine to Effectively Reduce Prostate Cancer Cell Proliferation, Migration Levels, and Increase Apoptosis

(1) American Heritage School, Miami, Florida

Cover photo for Testing the Effects of Resveratrol, Apigenin, and Glucosamine to Effectively Reduce Prostate Cancer Cell Proliferation, Migration Levels, and Increase Apoptosis

The current five-year survival rate of metastasized prostate cancer is only 30% and occurs in every one in nine men. Researchers have shown that people with a type of dwarfism called Laron’s Syndrome are immune to cancer due to their low levels of insulin-like growth factor-1 (IGF-1). For this reason, experimentally modifying the level of IGF-1 could provide better insight into whether lowering the levels of IGF-1 in prostate cancer cell lines (e.g. PC-3) could be an effective treatment to reduce their rates of proliferation and migration and increase apoptosis. We selected three compounds, which researchers have shown decrease IGF-1 levels, to test and combine to determine which is the most promising. We conducted a cell proliferation assay in order to determine the impact of each treatment on cell proliferation. We used a migration assay to measure the migration of the PC-3 cells after each treatment. In this assay, we seeded bone marrow mesenchymal stromatolites cells (BM-MSC) underneath the PC-3 cells to induce migration. Finally, we conducted an apoptosis assay to count the number of cell deaths after treating the PC-3 cells. The compounds we used, glucosamine, apigenin, and resveratrol, can be found naturally in foods or supplements. We found the treatment with a combination of all three compounds to be most effective in decreasing cell proliferation and migration levels in the PC-3 cells. In the cell apoptosis assay, the glucosamine and apigenin combination caused the largest number of cell deaths, but an outlier in this condition resulted in a large margin of error. The combination of all three compounds resulted in the second highest number of cell deaths. With these results and further investigation, a potential new, less costly, and less painful treatment for prostate cancer could be found.

Download Full Article as PDF

This article has been tagged with: